{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Methods: A randomised controlled trial was conducted"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "Participants were randomly assigned to either videolaryngoscope-guided or direct laryngoscope-guided DLT intubation."
      },
      "Participants": {
        "score": 1,
        "evidence": "participants having predicted normal airways"
      },
      "Intervention": {
        "score": 2,
        "evidence": "videolaryngoscope-guided or direct laryngoscope-guided DLT intubation"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the effectiveness of videolaryngoscopes in thoracic airway management"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the success rate of DLT intubation on the first attempt, measured immediately post-intubation."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised: 100 to the videolaryngoscope group and 100 to the direct laryngoscope group, between January 2020 and June 2021."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "In the intention-to-treat analysis, 98 participants in the videolaryngoscope group and 97 in the direct laryngoscope group were analysed."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The videolaryngoscope group showed a higher first-attempt success rate (mean difference = 12%, 95% CI 5% to 19%; p = 0.002)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were reported in 3% of the videolaryngoscope group and 1% of the direct laryngoscope group, with mild severity."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT12345678."
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: Supported by the National Natural Science Foundation of P.R. China (No. 82171228) and China National Key R&D Program (No. 2020YFC2009002)."
      }
    },
    "total_score": 22,
    "max_score": 25
  },
  "model": "gpt-4o"
}